Celldex Therapeutics, Inc. 4
4 · Celldex Therapeutics, Inc. · Filed Dec 10, 2013
Insider Transaction Report
Form 4
LIPTON KAREN SHOOS
Director
Transactions
- Sale
Common Stock
2013-12-06$24.50/sh−17,728$434,336→ 13,333 total - Exercise/Conversion
Common Stock
2013-12-06$8.16/sh+17,728$144,660→ 31,061 total - Exercise/Conversion
Non-Qualified Stock Option
2013-12-06−17,728→ 0 totalExercise: $8.16From: 2009-03-07Exp: 2015-03-07→ Common Stock (17,728 underlying)